Business
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope – NEWS.com.au
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope
A participant in AstraZenecas coronavirus vaccine trial triggered a global shutdown of the promising vaccine after she experienced worrying neurological symptoms.The woman’s symptoms were consistent with transverse myelitis, a serious spinal inflammatory disorder that can cause bladder problems, muscle weakness, pain and at worst, paralysis.
AstraZeneca chief executive Pascal Soriot revealed the woman’s symptoms in a private conference call with investors yesterday, information that was later s…
-
Noosa News14 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General16 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
Noosa News17 hours agoRaising your voice | Noosa Today
-
Noosa News7 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs